Northern Trust Corp Sells 9,670 Shares of LivaNova PLC $LIVN

Key Points

• Northern Trust Corp reduced its stake in LivaNova PLC by 1.4%, selling 9,670 shares, which brings its total ownership down to approximately 693,349 shares valued at about $27.2 million.
• Analysts have raised their ratings and target prices on LivaNova shares, with one firm upgrading it to a "strong-buy" rating and a consensus target price of $59.71.
• LivaNova reported a quarterly earnings jump, posting EPS of $1.05, above expectations, and revenue of $352.5 million, indicating a year-over-year growth of 10.6%.

Northern Trust Corp decreased its holdings in LivaNova PLC (NASDAQ:LIVN - Free Report) by 1.4% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 693,349 shares of the company's stock after selling 9,670 shares during the quarter. Northern Trust Corp owned approximately 1.27% of LivaNova worth $27,235,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Mariner LLC increased its holdings in LivaNova by 8.4% in the fourth quarter. Mariner LLC now owns 5,741 shares of the company's stock valued at $266,000 after purchasing an additional 446 shares during the last quarter. Tower Research Capital LLC TRC grew its stake in LivaNova by 122.9% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,422 shares of the company's stock valued at $251,000 after acquiring an additional 2,989 shares during the period. Hsbc Holdings PLC grew its stake in LivaNova by 25.5% in the fourth quarter. Hsbc Holdings PLC now owns 5,876 shares of the company's stock valued at $272,000 after acquiring an additional 1,193 shares during the period. Price T Rowe Associates Inc. MD grew its stake in LivaNova by 11.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 37,180 shares of the company's stock valued at $1,722,000 after acquiring an additional 3,839 shares during the period. Finally, The Manufacturers Life Insurance Company grew its stake in LivaNova by 163.6% in the fourth quarter. The Manufacturers Life Insurance Company now owns 546,387 shares of the company's stock valued at $25,303,000 after purchasing an additional 339,139 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Wall Street Zen raised LivaNova from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th. Robert W. Baird lifted their price target on LivaNova from $55.00 to $61.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Barclays lifted their price target on LivaNova from $55.00 to $58.00 and gave the company an "equal weight" rating in a research note on Thursday, August 21st. Wolfe Research upgraded LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 price objective on the stock in a research report on Tuesday, May 20th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $64.00 price objective on shares of LivaNova in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $59.71.

LivaNova Stock Up 2.2%

Shares of LivaNova stock traded up $1.23 on Thursday, hitting $57.82. The company had a trading volume of 173,385 shares, compared to its average volume of 701,954. The stock has a market capitalization of $3.16 billion, a price-to-earnings ratio of -14.86 and a beta of 0.97. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.09 and a current ratio of 1.29. The stock has a 50 day moving average of $48.18 and a 200-day moving average of $43.53. LivaNova PLC has a 1 year low of $32.48 and a 1 year high of $57.93.

LivaNova (NASDAQ:LIVN - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.21. LivaNova had a positive return on equity of 14.57% and a negative net margin of 16.13%.The company had revenue of $352.50 million during the quarter, compared to analyst estimates of $332.20 million. During the same period in the prior year, the company posted $0.93 earnings per share. LivaNova's quarterly revenue was up 10.6% on a year-over-year basis. As a group, sell-side analysts forecast that LivaNova PLC will post 2.85 earnings per share for the current year.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.